Safety and efficacy of conversion from once daily sandimmun to twice daily neoral cyclosporine in renal allograft recipients

By Vathsala A.   Lee W.T.   Lu Y.-M.   Woo K.T.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1746-1748

Elsevier

Access to resources Recommend Favorite

Conversion From Cyclosporine Sandimmune to Cyclosporine Neoral in the Stable Renal Transplant Population

By Griffin P.J.A.   Moore R.H.   Jurewicz W.A.   Lord R.H.H.   Webley Y.   Jenkins J.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 303-303

Elsevier

Access to resources Recommend Favorite

Safety of conversion from cyclosporine sandimmune to cyclosporine neoral in stable liver transplant patients

By Baruch Y.   Assy N.   Kramsky R.   Enat R.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1852-1853

Elsevier

Access to resources Recommend Favorite

Conversion from the conventional cyclosporine formulation (sandimmune) to a new oral microemulsion (neoral) in stable liver transplant patients

By Dibo-Cohen J.M.   Conort O.   Conti F.   Bernard D.   Hazebroucq G.   Calmus Y.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1857-1857

Elsevier

Access to resources Recommend Favorite

Comparative study of population pharmacokinetics upon switching of cyclosporine formulation from sandimmune to neoral in stable renal transplant patients

By Yoshida K.   Kimura T.   Hamada Y.   Saito T.   Endo T.   Baba S.   Shimada S.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3146-3147

Elsevier

Access to resources Recommend Favorite